An evaluation of gout visits in the United States for the years 2007 to 2011
Abstract Background This study analyzed visits for and factors associated with gout and gout medication treatment trends for the years 2007–2011 in the United States given the introduction of febuxostat, the first new treatment option for gout in over 40 years, which was introduced to the market in...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-05-01
|
| Series: | BMC Rheumatology |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s41927-018-0020-0 |
| _version_ | 1811208400313253888 |
|---|---|
| author | Kristen E. Castro Kaitlyn D. Corey Diana L. Raymond Michael R. Jiroutek Melissa A. Holland |
| author_facet | Kristen E. Castro Kaitlyn D. Corey Diana L. Raymond Michael R. Jiroutek Melissa A. Holland |
| author_sort | Kristen E. Castro |
| collection | DOAJ |
| description | Abstract Background This study analyzed visits for and factors associated with gout and gout medication treatment trends for the years 2007–2011 in the United States given the introduction of febuxostat, the first new treatment option for gout in over 40 years, which was introduced to the market in 2009. Methods This study was a retrospective, cross-sectional, observational study of patients age 20 and older seen by providers who participated in the National Ambulatory Medical Care Survey (NAMCS), the National Hospital Ambulatory Medical Care Survey Outpatient Department (NHAMCS-OPD) or Emergency Department (NHAMCS-ED) in the United States. The outcome of interest was visits for gout diagnosis and visits where a gout medication was prescribed. Results Approximately 1.2% of visits had a diagnosis of gout. There was a significant increase in the percentage of visits with a diagnosis of gout in years 2009–2011 compared to 2007–2008, which remained after adjusting for covariates of interest. Groups more likely to have a visit with gout included those ≥65 and 45–64 (both as compared to those 20–44), the African-American and ‘Other’ race groups (as compared to Caucasians) and those on a diuretic. Groups less likely to have a visit with gout included females, Hispanic/Latinos, those with insurance type of ‘Other’ and Medicaid (both as compared to private insurance) and visits to a hospital emergency setting (as compared to physician’s office visits). Conclusion Although there was a significant increase in visits where gout is diagnosed across study years, the overall percentage of visits with a gout diagnosis is low in the US population. Treatment trends over the study years has remained consistent, with the introduction of febuxostat appearing to have little impact for the study years through 2011. |
| first_indexed | 2024-04-12T04:20:36Z |
| format | Article |
| id | doaj.art-f1a3955bb2c940d9b6df6e89439f50da |
| institution | Directory Open Access Journal |
| issn | 2520-1026 |
| language | English |
| last_indexed | 2024-04-12T04:20:36Z |
| publishDate | 2018-05-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Rheumatology |
| spelling | doaj.art-f1a3955bb2c940d9b6df6e89439f50da2022-12-22T03:48:15ZengBMCBMC Rheumatology2520-10262018-05-01211910.1186/s41927-018-0020-0An evaluation of gout visits in the United States for the years 2007 to 2011Kristen E. Castro0Kaitlyn D. Corey1Diana L. Raymond2Michael R. Jiroutek3Melissa A. Holland4Campbell University College of Pharmacy & Health SciencesCampbell University College of Pharmacy & Health SciencesCampbell University College of Pharmacy & Health SciencesCampbell University College of Pharmacy & Health SciencesCampbell University College of Pharmacy & Health SciencesAbstract Background This study analyzed visits for and factors associated with gout and gout medication treatment trends for the years 2007–2011 in the United States given the introduction of febuxostat, the first new treatment option for gout in over 40 years, which was introduced to the market in 2009. Methods This study was a retrospective, cross-sectional, observational study of patients age 20 and older seen by providers who participated in the National Ambulatory Medical Care Survey (NAMCS), the National Hospital Ambulatory Medical Care Survey Outpatient Department (NHAMCS-OPD) or Emergency Department (NHAMCS-ED) in the United States. The outcome of interest was visits for gout diagnosis and visits where a gout medication was prescribed. Results Approximately 1.2% of visits had a diagnosis of gout. There was a significant increase in the percentage of visits with a diagnosis of gout in years 2009–2011 compared to 2007–2008, which remained after adjusting for covariates of interest. Groups more likely to have a visit with gout included those ≥65 and 45–64 (both as compared to those 20–44), the African-American and ‘Other’ race groups (as compared to Caucasians) and those on a diuretic. Groups less likely to have a visit with gout included females, Hispanic/Latinos, those with insurance type of ‘Other’ and Medicaid (both as compared to private insurance) and visits to a hospital emergency setting (as compared to physician’s office visits). Conclusion Although there was a significant increase in visits where gout is diagnosed across study years, the overall percentage of visits with a gout diagnosis is low in the US population. Treatment trends over the study years has remained consistent, with the introduction of febuxostat appearing to have little impact for the study years through 2011.http://link.springer.com/article/10.1186/s41927-018-0020-0GoutFebuxostatNAMCSNHAMCS-OPDNHAMCS-ED |
| spellingShingle | Kristen E. Castro Kaitlyn D. Corey Diana L. Raymond Michael R. Jiroutek Melissa A. Holland An evaluation of gout visits in the United States for the years 2007 to 2011 BMC Rheumatology Gout Febuxostat NAMCS NHAMCS-OPD NHAMCS-ED |
| title | An evaluation of gout visits in the United States for the years 2007 to 2011 |
| title_full | An evaluation of gout visits in the United States for the years 2007 to 2011 |
| title_fullStr | An evaluation of gout visits in the United States for the years 2007 to 2011 |
| title_full_unstemmed | An evaluation of gout visits in the United States for the years 2007 to 2011 |
| title_short | An evaluation of gout visits in the United States for the years 2007 to 2011 |
| title_sort | evaluation of gout visits in the united states for the years 2007 to 2011 |
| topic | Gout Febuxostat NAMCS NHAMCS-OPD NHAMCS-ED |
| url | http://link.springer.com/article/10.1186/s41927-018-0020-0 |
| work_keys_str_mv | AT kristenecastro anevaluationofgoutvisitsintheunitedstatesfortheyears2007to2011 AT kaitlyndcorey anevaluationofgoutvisitsintheunitedstatesfortheyears2007to2011 AT dianalraymond anevaluationofgoutvisitsintheunitedstatesfortheyears2007to2011 AT michaelrjiroutek anevaluationofgoutvisitsintheunitedstatesfortheyears2007to2011 AT melissaaholland anevaluationofgoutvisitsintheunitedstatesfortheyears2007to2011 AT kristenecastro evaluationofgoutvisitsintheunitedstatesfortheyears2007to2011 AT kaitlyndcorey evaluationofgoutvisitsintheunitedstatesfortheyears2007to2011 AT dianalraymond evaluationofgoutvisitsintheunitedstatesfortheyears2007to2011 AT michaelrjiroutek evaluationofgoutvisitsintheunitedstatesfortheyears2007to2011 AT melissaaholland evaluationofgoutvisitsintheunitedstatesfortheyears2007to2011 |